ReviewCurrent pharmaceutical design2014

Choosing optimal first-line Helicobacter pylori therapy: a view from a region with high rates of antibiotic resistance.

Alexander A Nijevitch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.